iPath Pure Beta Lead ETN
LEDD
LEDD was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $64K invested in iPath Pure Beta Lead ETN in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
56% more capital invested
Capital invested by funds: $41K → $64K (+$23K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$27.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
1
UBS
Zurich,
Switzerland
| $59K | +$27.7K | +712 | +77% |
|
2
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
LEDD Hedge Fund Activity: Q3 2014 in Review
2 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Lead ETN (LEDD) for Q3 2014, worth a combined $64K — up 56% from $41K a quarter earlier.
Fund positioning in LEDD was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS, adding an estimated $27.7K.
- 2 institutional investors held iPath Pure Beta Lead ETN (LEDD) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $64K of iPath Pure Beta Lead ETN stock for Q3 2014, up 56% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Lead ETN positions in Q3 2014 and 0 closed out.
- The largest iPath Pure Beta Lead ETN buyer in Q3 2014 was UBS, an estimated $27.7K added.
Based on aggregated 13F filings for Q3 2014.